Abrocitinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Abrocitinib, covering 2022-07-08 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema [Phase 3]